1.3.1.92: artemisinic aldehyde DELTA11(13)-reductase
This is an abbreviated version!
For detailed information about artemisinic aldehyde DELTA11(13)-reductase, go to the full flat file.
Word Map on EC 1.3.1.92
-
1.3.1.92
-
artemisinin
-
annua
-
artemisia
-
trichomes
-
cyp71av1
-
amorpha-4,11-diene
-
glandular
-
trichome-specific
-
antimalarial
-
dihydroartemisinic
-
hydroxylase
-
malaria
-
synthesis
-
medicine
-
drug development
- 1.3.1.92
- artemisinin
- annua
-
artemisia
- trichomes
- cyp71av1
- amorpha-4,11-diene
- glandular
-
trichome-specific
-
antimalarial
-
dihydroartemisinic
- hydroxylase
-
malaria
- synthesis
- medicine
- drug development
Reaction
Synonyms
artemisinic aldehyde DELTA11(13) double bond reductase2, artemisinic aldehyde DELTA11(13) double-bond reductase, artemisinic aldehyde DELTA11(13) reductase, Dbr2, double bond reductase 2, double-bond reductase 2
ECTree
Advanced search results
Application
Application on EC 1.3.1.92 - artemisinic aldehyde DELTA11(13)-reductase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
oral feeding of whole intact plant cells bioencapsulating the artemisinin reduces the Plasmodium falciparum parasitemia levels in challenged mice in comparison with commercial drug. The synergistic approache may facilitate low-cost production and delivery of artemisinin and other drugs through metabolic engineering of edible plants
medicine
artemisinin is the main ingredient for malaria prevention. The World Health Organization recommends artemisinin combination therapies (ACT) as the first-line therapy for malaria worldwide
synthesis
-
production of artemisin by incubating a mixture of artemisin precursors from engineered Saccharomyces cerevisiae with a cell-free extract of Artemisia annua. Use of cold-acclimated Artemisia annua cell-free extract gives rise to considerable artemisin content up to 0.65%
synthesis
for enhanced artemisin production, Appropriate doses of Cd can increase the concentrations of artemisinic metabolites at a certain time point by upregulating the relative expression levels of key enzyme genes involved in artemisinin biosynthesis